I own both companies but way more heavily invested in Freelancer. There is no way it is overvalued and it is by far the best at what it does and has first mover market advantage. Given its quarterly was just released and there was a clear $1.9m cash positive... I think it is not over valued at all as I could see that being around 10mil by year end. The world is its oyster now and I cannot see any competitor coming along and grabbing a considerable market share over it. In addition its acquisition of Escrow was a genius move.
- Forums
- ASX - By Stock
- UNT
- Record cash receipts for 4th quarter
Record cash receipts for 4th quarter, page-6
-
-
- There are more pages in this discussion • 236 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add UNT (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.3¢ |
Change
-0.001(7.14%) |
Mkt cap ! $15.97M |
Open | High | Low | Value | Volume |
1.3¢ | 1.3¢ | 1.3¢ | $3.906K | 300.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 5651798 | 1.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.4¢ | 918236 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 5651798 | 0.013 |
14 | 3328379 | 0.012 |
2 | 632304 | 0.011 |
6 | 1488966 | 0.010 |
2 | 1100000 | 0.009 |
Price($) | Vol. | No. |
---|---|---|
0.014 | 918236 | 5 |
0.015 | 849000 | 4 |
0.016 | 240962 | 4 |
0.017 | 766142 | 4 |
0.018 | 1108178 | 3 |
Last trade - 10.53am 12/11/2024 (20 minute delay) ? |
Featured News
UNT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online